ABBV
AbbVie Inc.
Healthcare
$214.50
as of May 21, 2026
Sign in to add ABBV to your portfolio.
Sign inMarket cap
$375.13B
P/E (TTM)
103.5x
EPS (TTM)
$2.05
Dividend yield
3.17%
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $56.20B | $11.54B | $21.99B | 69.0% | 31.9% | $6.48 |
| 2022 | $58.05B | $11.84B | $24.25B | 70.0% | 31.2% | $6.65 |
| 2023 | $54.32B | $4.86B | $22.06B | 62.4% | 23.5% | $2.73 |
| 2024 | $56.33B | $4.28B | $17.83B | 70.0% | 16.2% | $2.40 |
| 2025 | $61.16B | $4.23B | $17.82B | 70.2% | 32.8% | $2.37 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $210.95 | $214.50 | 3.81M |
| May 20, 2026 | $213.36 | $212.30 | 5.13M |
| May 19, 2026 | $209.90 | $213.76 | 7.22M |
| May 18, 2026 | $210.37 | $209.41 | 4.75M |
| May 15, 2026 | $213.10 | $210.39 | 5.39M |
| May 14, 2026 | $209.50 | $210.77 | 5.01M |
| May 13, 2026 | $206.86 | $208.50 | 5.71M |
| May 12, 2026 | $204.59 | $207.86 | 7.04M |
| May 11, 2026 | $202.01 | $202.78 | 4.93M |
| May 08, 2026 | $201.92 | $201.55 | 4.92M |
| May 07, 2026 | $204.92 | $202.71 | 6.68M |
| May 06, 2026 | $206.11 | $205.03 | 7.29M |
| May 05, 2026 | $208.97 | $206.11 | 4.49M |
| May 04, 2026 | $205.71 | $208.16 | 4.58M |
| May 01, 2026 | $211.00 | $206.60 | 6.34M |
| Apr 30, 2026 | $209.00 | $211.32 | 10.32M |
| Apr 29, 2026 | $192.00 | $203.89 | 10.41M |
| Apr 28, 2026 | $198.67 | $197.69 | 6.31M |
| Apr 27, 2026 | $198.00 | $197.38 | 7.47M |
| Apr 24, 2026 | $198.93 | $198.71 | 7.61M |
| Apr 23, 2026 | $201.05 | $200.95 | 7.46M |
| Apr 22, 2026 | $205.17 | $200.50 | 7.65M |
| Apr 21, 2026 | $204.01 | $205.12 | 7.77M |
| Apr 20, 2026 | $207.94 | $203.71 | 5.77M |
Profitability & balance
- ROE (TTM)
- 68.0%
- Gross margin
- 73.5%
- Operating margin
- 27.6%
- Net margin
- 5.8%
- Debt / equity
- 2.65